Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
Condition(s):Neurofibromatosis 1Last Updated:February 11, 2016Unknown status
Hide Studies Not Open or Pending
Condition(s):Neurofibromatosis 1Last Updated:February 11, 2016Unknown status
Condition(s):Neurofibromatosis 1Last Updated:January 31, 2019Completed
Condition(s):Neurofibromatosis Type 1Last Updated:March 26, 2015Completed
Condition(s):Neurofibromatosis Type 1Last Updated:April 14, 2020Terminated
Condition(s):Neurofibromatosis Type 1Last Updated:August 19, 2015Completed
Condition(s):Neurofibromatosis 1; Neurofibromatosis 2; SchwannomatosisLast Updated:August 30, 2023Recruiting
Condition(s):Neurofibromatosis 1; Nerve Sheath NeoplasmsLast Updated:March 27, 2024Not yet recruiting
Condition(s):Neurofibromatosis 1Last Updated:March 27, 2024Recruiting
Condition(s):Neurofibromatosis Type 1Last Updated:July 25, 2017Completed
Condition(s):Neurofibromatosis Type 1Last Updated:June 25, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.